These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14244111)

  • 1. STUDIES ON THE ROLE OF ACTIVE IMMUNIZATION IN THE PREVENTION OF CHOLERA EL TOR.
    BERAN GW; ELVINA O; FLORENDO FN
    J Philipp Med Assoc; 1964 Feb; 40():122-35. PubMed ID: 14244111
    [No Abstract]   [Full Text] [Related]  

  • 2. AGGLUTINATING, LETHAL TOXIN AND E1 TOR HAEMOLYSIN NEUTRALIZING POTENCY OF SERA IN CHOLERA.
    FELSENFELD O; NASUNIYA N; WATANABE Y; PENA A; DALE BN
    Bull World Health Organ; 1964; 30(6):833-44. PubMed ID: 14215189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE 1961 CHOLERA EPIDEMIC IN MANILA, REPUBLIC OF THE PHILIPPINES.
    WALLACE CK; FABIE AE; MANGUBAT O; VELASCO E; JUINIO C; PHILLIPS RA
    Bull World Health Organ; 1964; 30(6):795-810. PubMed ID: 14215186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines. Preliminary report; Philippines Cholera Committee.
    Philippines Cholera Committee
    Bull World Health Organ; 1965; 32(5):603-25. PubMed ID: 5294176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.
    Azurin JC; Cruz A; Pesigan TP; Alvero M; Camena T; Suplido R; Ledesma L; Gomez CZ
    Bull World Health Organ; 1967; 37(5):703-27. PubMed ID: 5300874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEROLOGICAL STUDIES IN EL TOR CHOLERA.
    BASACA-SEVILLA V; PESIGAN TP
    J Philipp Med Assoc; 1964 Dec; 40():SUPPL:1039-84. PubMed ID: 14282496
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current problems of epidemiology and prevention of El Tor cholera].
    Teodorovici G
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):1-7. PubMed ID: 5552559
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled field trial of the effectiveness of monovalent classical and El Tor cholera vaccines in the Philippines.
    Philippines Cholera Committee
    Bull World Health Organ; 1973; 49(1):13-9. PubMed ID: 4596491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serum agglutinin titer of healthy children after cholera-sec immunization and its influence on paracholera El Tor.
    Sutan Assin M; Sutedjo ; Tyia SOE KHIE ; Talogo W
    Paediatr Indones; 1965; 5(1-2):629-36. PubMed ID: 5874189
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled field trial of the effectiveness of various doses of cholera El Tor vaccine in the Philippines.
    Philippines Cholera Committee
    Bull World Health Organ; 1968; 38(6):917-23. PubMed ID: 5303665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEROLOGICAL STUDIES ON CHOLERA. II. ANTIBODY LEVELS OBSERVED IN EXPERIMENTALLY VACCINATED MONKEYS.
    BERAN GW
    Am J Trop Med Hyg; 1964 Sep; 13():708-15. PubMed ID: 14205891
    [No Abstract]   [Full Text] [Related]  

  • 12. CHOLERA EL TOR IN CALCUTTA.
    MUKERJEE S
    Br Med J; 1964 Aug; 2(5408):546-8. PubMed ID: 14173185
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective activity of cholera vaccines against E1 Tor cholera vibrios.
    PITTMAN M; FEELEY JC
    Bull World Health Organ; 1963; 28(3):379-83. PubMed ID: 13943861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholera incidence in a population offered cholera vaccination: comparison of cooperative and uncooperative groups.
    Azurin JC; Alvero M
    Bull World Health Organ; 1971; 44(6):815-9. PubMed ID: 4950563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.
    Capeding MRZ; Gonzales MLAM; Dhingra MS; D'Cor NA; Midde VJ; Patnaik BN; Thollot Y; Desauziers E
    Hum Vaccin Immunother; 2017 Oct; 13(10):2232-2239. PubMed ID: 28910563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human volunteer studies using el tor cholera vaccines. I. Post-vaccinal reactions.
    Beran GW; Elviña O; Florendo FN
    J Philipp Med Assoc; 1965 Mar; 41(3):183-90. PubMed ID: 5318020
    [No Abstract]   [Full Text] [Related]  

  • 17. EL TOR VIBRIO FROM CASES OF CHOLERA IN CALCUTTA.
    BARUA D; MUKHERJEE AC; SACK B
    Bull Calcutta Sch Trop Med; 1964 Apr; 12():55-6. PubMed ID: 14240687
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROBLEMS OF CHOLERA (EL TOR).
    MUKERJEE S
    Am J Trop Med Hyg; 1963 May; 12():388-92. PubMed ID: 14044750
    [No Abstract]   [Full Text] [Related]  

  • 20. SEROLOGICAL STUDIES ON CHOLERA. I. ANTIBODY LEVELS OBSERVED IN VACCINATED AND CONVALESCENT PERSONS.
    BERAN GW
    Am J Trop Med Hyg; 1964 Sep; 13():698-707. PubMed ID: 14205890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.